Hazra Lab

Digital Transformation

Research Funding

The Hazra Lab is supported by leading national and international agencies, driving innovation in structural biology and antimicrobial research.

Ongoing Projects

PIICMR

Development and Clinical Validation of an Artificial Intelligence-empowered antibiotic susceptibility device towards optimizing antimicrobial therapy regimen in leukemia & bone marrow transplant patients

2024 - 2028

PIBRNS

β-lactamase attached protein detection by designing a BODIPY β-lactam compound

2024 - 2027

PIICMR-Intramural

Diagnostics for Hypervirulent Klebsiella pneumoniae causing sepsis targeting Resistance and Virulence determinants (DHRUV)

2024 - 2027

PIDHR-ICMR

Fabrication of anti AMR coated bioabsorbable rigid internal fixation system using Indigenous biosynthesized polymer

2023 - 2026

Co-PIIWMI

Hydrological Water quality and Antimicrobial Resistance Modelling of the Song river basin

2023 - 2026

Co-PIDBT

Translational and structural Bioinformatics – BIC at Department of Biotechnology, Indian Institute of Technology, Roorkee

2021 - 2026

Co-PIDBT

National Network Project (Structure based identification of antimicrobial compounds) of the Department of Biotechnology at Indian Institute of Technology, Roorkee

2021 - 2026

Completed Portfolios

PIDST-TIH

Development of catheter-based point-of-care rapid multi-stage diagnostics towards surveillance of patients with urinary tract infections

2022 - 2024

PIUKERI

Combating Carbapenem Resistance Enterobactriacae (CRE)

2019 - 2023

PISPARC (MHRD)

Combating Carbapenem Resistance Enterobactriacae (CRE): Using a combinatorial approach of conventional therapeutics and theranosticnanomedicine

2019 - 2023

Co-PIDBT-BIRAC

Edible oil blend from lignocellulosic pentosans and other raw materials

2018 - 2021

PIICMR

Developing novel antimicrobial therapeutics by exploring multi-enzyme targets.

2017 - 2020

PISERB-DST

Development of Novel therapeutics against drug resistant beta-lactamases.

2015 - 2018

PIMHRD/FIG

Identification and characterization of novel inhibitors against medicinally important beta-lactamases.

2014 - 2017